Grape King Bio Ltd. (1707) Stock Price & Analysis
1707 Stock Chart & Stats
- Day’s Range
- TWD 78.70 - TWD 81.50
- 52-Week Range
- TWD 78.70 - TWD 130.00
- Previous Close
- TWD 82.00
- Volume
- N/A
- Average Volume (3M)
- 240.55K
- Market Cap
- TWD 11.93B
- Enterprise Value
- TWD 11.53B
- Total Cash (Recent Filing)
- TWD 3.70B
- Total Debt (Recent Filing)
- TWD 186.69M
- Price to Earnings (P/E)
- 10.4
- Beta
- 0.11
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Jun 17, 2026
- Dividend Yield
- 7.45%
1707 FAQ
What was Grape King Bio Ltd.’s price range in the past 12 months?
What is Grape King Bio Ltd.’s market cap?
When is Grape King Bio Ltd.’s upcoming earnings report date?
How were Grape King Bio Ltd.’s earnings last quarter?
Is Grape King Bio Ltd. overvalued?
Does Grape King Bio Ltd. pay dividends?
What is Grape King Bio Ltd.’s EPS estimate?
How many shares outstanding does Grape King Bio Ltd. have?
What happened to Grape King Bio Ltd.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Grape King Bio Ltd.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Grape King Bio Ltd.
Grape King Bio Ltd. is a Taiwanese enterprise specializing in the production and distribution of a diverse array of health-focused items, encompassing pharmaceuticals, traditional remedies, nourishing beverages, and dietary supplements. Its market presence spans Taiwan, mainland China, and various international regions. The company engages with customers through multiple operational avenues, including multi-level marketing channels, conventional distribution networks, and a significant original design and equipment manufacturing (ODM/OEM) division. Among its extensive product range are various mushroom mycelium derivatives, notably ganoderma lucidum, agaricus blazei, antrodia cinnamomea, cordyceps sinensis, and coriolus versicolor. Additionally, it formulates and supplies probiotics featuring strains like enterococcus, bifidobacterium, lactobacillus, pediococcus, streptococcus, saccharomyces, and clostridium, alongside a selection of enzyme products. Beyond its own brand, Grape King Bio offers comprehensive contract services, such as original equipment manufacturing (OEM), original design manufacturing (ODM), custom formulation development, dedicated research and development support, and the provision of raw materials. Established in 1969, the firm maintains its corporate headquarters in Taoyuan City, Taiwan.
- Sector
- General
- Industry
- Medical - Pharmaceuticals
- CEO
- Sheng-Lin Tseng
- Employees
- 501
- Website
- www.grapeking.com.tw
- Address
- Jinling Road, Taoyuan City, TYC, 324, TW
Grape King Bio Ltd. (1707) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 6 | 2 | 14 |
| Technical Analysis | 6 | 2 | 2 |
| Moving Averages | 0 | 0 | 12 |

